Navigation Links
Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell Malignancies
Date:12/10/2013

y Reduces Clonal IgM Paraproteins and Serum Free Light Chains While Increasing Normal IgM, IgA Serum Levels, Suggesting a Nascent Recovery Of Humoral Immunity
Georg Aue, MD, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

This study demonstrated ibrutinib's impact on the recovery of humoral immunity equally amongst treatment naive and relapsed refractory CLL patients. Consistent with other reports we see little change in IgG levels in the first 12 months. Importantly, ibrutinib leads to a significant increase in both IgA and IgM serum levels, suggesting a beginning recovery of humoral immunity. The reduction of clonal light chains, a tumor marker, correlates with clinical response. In contrast, the increasing levels of the non-clonal light chain may herald a recovery of the normal B-cell (and possibly plasma cell compartment) raising the possibility that ibrutinib may selectively target CLL cells while allowing the re-growth of normal B-cells.

Poster Abstract #4166: Kinetics Of Chronic Lymphocytic Leukemia Cells In Tissues and Blood During Therapy With The BTK Inhibitor Ibrutinib
Dominik Wodarz, Department of Ecology and Evolutionary Biology, University of California Irvine, Irvine, CA

This two-compartment analysis provides greater insight into ibrutinib's mechanism of action in CLL. During ibrutinib therapy, on average 1.7% (± 1.1%) of the cells die per day in the blood, while in tissue 2.7% (± 0.99%) of the cells die per day. These death rates during treatment are approximately 3-5 times higher than those estimated in previous studies in the absence of treatment. The amount of CLL cells from the tissue that was redistributed into the blood during ibrutinib therapy accounted for an average of 23.3% (± 17%) of the calcula
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. WuXi PharmaTech to Partner with Pharmacyclics
2. Pharmacyclics Reports Third Quarter 2013 Results
3. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
4. Pharmacyclics Reports Second Quarter 2013 Results
5. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
6. Pharmacyclics Reports First Quarter 2013 Results
7. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
8. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
9. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
10. Pharmacyclics, Inc. Prices Public Offering of Common Stock
11. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 The Competitive Intelligence ... and marketplace changes. CI leaders who adjust will succeed, ... In a new Best Practices, LLC study CI leaders ... insights, including: - Use secondary research whenever ... research - Internal staff who are creative ...
(Date:8/29/2014)... SAN DIEGO , Aug. 29, 2014 /PRNewswire/ ... an emerging biopharmaceutical company, announced today that Santosh ... will be leaving the Company, for personal reasons, ... the Chief Medical Officer of Aires Pharmaceuticals, which ... Vetticaden,s former responsibilities as the Company,s interim Chief ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "China Orthopedic Instrument Industry Report, 2014-2017" report to ... population and rising proportion of reimbursement for medical expenses, ... released, with its scale presenting a CAGR of 19.2% ... are three product segments of orthopedic instruments in ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2
... N.J., July 15, 2011 Crestor and ... to lower "bad cholesterol". Both drugs are classified as ... HMG-CoA reductase. This group of drugs has had a ... Crestor and Zocor, touted as a "super statin" before ...
... -- CoLucid Pharmaceuticals, Inc., a privately held biopharmaceutical company, ... as Chief Executive Officer. Mr. Mathers has ... marketing experience in the life sciences and medical device ... for the Biotechnology Industry Organization (BIO), and as chairman ...
Cached Medicine Technology:Crestor and Zocor Drugs Linked to Muscle Degeneration, Rhabdomyolysis 2CoLucid Appoints Thomas P. Mathers as Chief Executive Officer 2
(Date:8/30/2014)... Recently, Top 10 Best SEO Hosting (Top10BestSEOHosting.com) has ... BlueHost and JustHost ( http://www.justhost.com/track/seohosts ) are great ... high quality web hosting. , “The hosting ... companies who outperform their competitors on hosting features, ... spokesman for Top 10 Best SEO Hosting says, ...
(Date:8/30/2014)... 2014 Recently, iFitDress.com, one of the ... designs of classy bridesmaid dresses . For additional ... 22 percent off to 62 percent off) for all ... items. , True enough, iFitDress.com is an industry ... gowns. The company persists in making trendy products that ...
(Date:8/30/2014)... August 31, 2014 Fast hosting ... websites. Top10BestSEOHosting.com has recently compared many professional web ... http://www.hostmonster.com/track/seohosts ) and Arvixe are the suppliers of ... hard to find a good fast hosting supplier. ... hosting features, uptime, server speed and customer support. ...
(Date:8/30/2014)... 31, 2014 Recently, Skmen.com, a well-known ... long casual dresses . Before the middle of September, ... a discounted price, from 15 to 30 percent off. ... company’s long casual outfits are carefully made and come ... look for the wearers. Skmen.com is popular for its ...
(Date:8/30/2014)... Information supplied by insurance companies has been helping ... consumers in 2014. A group of ratess for term ... open system for adults at http://quotespros.com/life-insurance.html . ... year can help the average person to quote a ... from medical histories. The finder tool works under a ...
Breaking Medicine News(10 mins):Health News:Great Web Hosting Suppliers Recently Recommended by Top10BestSEOHosting.com 2Health News:Classy Bridesmaid Dresses Announced By Loved Online Supplier iFitDress.com 2Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:Huge Deals On 2014 Long Casual Dresses Unveiled By Skmen.com 2Health News:Term Life Insurance Rates Now Found Nationally by New Insurer Finder Tool 2
... 27, 2008 Overweight Hispanic children with normal blood glucose ... may predispose them to developing both type 2 diabetes and ... the Joslin Diabetes Center. , The study, published in the ... on Hispanic children, already known to be at high risk ...
... the United States government should convert the Guantanamo ... research institute dedicated to combating diseases of poverty. ... Neglected Tropical Diseases, Editor-in-Chief Peter Hotez says that ... position to directly address the poverty-promoting diseases and ...
... Disputes, SPOKANE, Wash., Feb. 26 Recently, ... settlement on four,outstanding disputes. The approximately 110 nurses ... "This settlement is very important for the nurses, ... refusal to negotiate a fair,contract," said Buck Holliday, ...
... 26 Local communities,can be effective in preventing ... and heart disease if they use healthy eating ... principles identified by,leading national programs., Communities are ... nation. There are eight leading national programs which ...
... (Nasdaq: IDIX ) announced today that Idenix management,will ... in Healthcare Conference hosted by Susquehanna Financial Group on,Wednesday, ... W Hotel in the Sea/Ocean,Room in New York, NY., ... the company presentation,can be accessed under "Calendar of Events" ...
... Additional Benefit Found for Personalized Intervention to Promote ... interventions did not significantly increase regular mammography screening ... such as personalized mailings, have been reported to ... examined the impact of behavioral interventions on regular ...
Cached Medicine News:Health News:Overweight Hispanic children shown to have vascular inflammation 2Health News:From detainee facility to health advocacy center: A new role for Guantanamo? 2Health News:Nurses Convince Hospital to Return to Bargaining Table 2Health News:Effective Healthy Eating and Physical Activity Initiatives Can Reduce Health Disparities 2Health News:Other highlights in the Feb. 26 JNCI 2Health News:Other highlights in the Feb. 26 JNCI 3Health News:Other highlights in the Feb. 26 JNCI 4
... is an advanced three-part inflatable prosthesis consisting of ... placed in the scrotum and a pair of ... simulates the look and performance of a natural ... technology, the AMS 700 Series now features the ...
... is an advanced three-part inflatable prosthesis consisting of ... placed in the scrotum and a pair of ... simulates the look and performance of a natural ... technology, the AMS 700 Series now features the ...
... bags are part of the Freedom ... of leg bags, kits, and accessories ... of our customers. These leg bags ... constructed of 100% latex-free soft, textured ...
... part of the Freedom Urinary Collection ... bags, kits, and accessories designed to ... customers. These leg bags are offered ... 100% latex-free soft, textured medical grade ...
Medicine Products: